Pediatric Proliferative Glomerulonephritis with Monoclonal IgG Deposits: A Single-Center Case Series Highlighting Phenotypic and Treatment Heterogeneity (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #SA-PO0775; Pres time: Oct 24, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "She received cyclophosphamide for RPGN with crescentic lesion, daratumumab, and obinutuzumab, and losartan...Treatment has consisted of corticosteroids, MMF, and lisinopril...All received steroids and RAAS inhibition if able, but other immunosuppressants were chosen based on individua characteristics. Daratumumab was successfully used in a clone-negative pediatric patient (1), supporting considering use of anti-CD38 therapy without a plasma clone."
Clinical • Heterogeneity • Chronic Kidney Disease • Glomerulonephritis • Infectious Disease • Lupus Nephritis • Nephrology • Pediatrics • Renal Disease
|
|
Louise Barbara Sawaya; Charles D. Varnell
|